Ironwood Pharmaceuticals | IRWD - 营业费用



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.24
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 732.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 106.51M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


营业费用 更改 日
Acadia Pharmaceuticals USD 272.68M 6.08M 2026-03
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Almirall EUR 517.4M 32K 2025-12
Alnylam Pharmaceuticals USD 898.54M 66.78M 2026-03
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 127.27M 7.15M 2026-03
Astellas Pharma JPY 489.36B 52.69B 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Coherus Biosciences USD 51.83M 2.48M 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Halozyme Therapeutics USD 192.19M 18.88M 2026-03
Incyte USD 5.62B 4.5B 2026-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
MacroGenics USD 21.2M 32.13M 2026-03
Moderna USD 1.78B 242M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Pacira USD 172.75M 20.93M 2026-03
PTC Therapeutics USD 226.66M 19.64M 2026-03
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 372.37M 480.65M 2026-03
Takeda JPY 1.11T 85.29B 2026-03
Ultragenyx Pharmaceutical USD 305M 16M 2026-03
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12